Physician profile
William C Sutterfield
NPI 1427096510
$2,740.00
in general payments reported to CMS, 2019-2025
29 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $130 · 2021: $209 · 2022: $351 · 2023: $1,512 · 2024: $134 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,025 · Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,025.01 |
| Food and Beverage | $763.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,453.92 | 2020-2024 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $130.61 | 2020-2025 | Gattex |
| Tela Bio, INC. | $121.69 | 2021-2022 | |
| Stryker Corporation | $113.71 | 2023 | Spy-Phi System |
| Teleflex LLC | $94.73 | 2022-2025 | Titan Sgs Bailout Chuck, Quikclot |
| Intuitive Surgical, INC. | $87.17 | 2019 | |
| Merck Sharp & Dohme LLC | $81.60 | 2019-2024 | Bridion |
| Heron Therapeutics, INC. | $70.09 | 2023-2024 | Zynrelef, Aponvie |
| Baxter Healthcare | $65.07 | 2019 | |
| Allergan, INC. | $64.64 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $52.88 | 2025 | |
| Polynovo North America LLC | $40.63 | 2023-2024 | Novosorb Btm |
| Shire North American Group INC | $36.79 | 2019 | |
| W. L. Gore & Associates, INC. | $35.34 | 2019-2021 | |
| Baudax Bio INC. | $25.74 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $24.76 | 2022 | |
| Boston Scientific Corporation | $23.41 | 2022 | |
| Abbvie INC. | $23.38 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Innocoll Pharmaceuticals Limited | $21.36 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $20.17 | 2019 | |
| Endo Pharmaceuticals INC. | $19.96 | 2022 | |
| Kci USA, INC. | $19.45 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.17 | 2019 | |
| Conmed Corporation | $18.22 | 2025 | Airseal |
| Innovation Technologies INC | $16.77 | 2022 | |
| Angiodynamics, INC. | $16.31 | 2023 | Smart Port Ct |
| Acacia Pharma INC | $15.54 | 2021 | |
| Vivus LLC | $14.50 | 2021 | |
| Smith+Nephew, INC. | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sutterfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.